The airlift bioreactors market has seen considerable growth due to a variety of factors.
• The airlift bioreactors market will grow from $3.95 billion in 2024 to $4.38 billion in 2025 at a CAGR of 10.8%.
This growth is fueled by the increased demand for single-use bioreactors, the rising number of clinical and preclinical trials, a focus on bioprocessing efficiency, the demand from contract research organizations (CROs) and manufacturing organizations (CMOs), and government support for regulations.
The airlift bioreactors market is expected to maintain its strong growth trajectory in upcoming years.
• The airlift bioreactors market is forecast to reach $6.5 billion by 2029, growing at a CAGR of 10.4%.
The growth is attributed to the increasing demand for biochemicals, growing investments in healthcare, awareness of airlift bioreactors' benefits, and the rise of personalized medicine. Key trends include new players entering the market, airlift bioreactor use in vaccine production, sustainability, demand for high-density cell culture, and a focus on regulatory compliance.
Gain Insights Into The Airlift Bioreactors Global Market Report 2025 With A Free Sample Report Here:
The rising demand for biopharmaceutical products is expected to propel the growth of the airlift bioreactors market. Biopharmaceutical products, such as therapeutic proteins and vaccines, are in demand due to advancements in biotechnological processes and increasing incidences of chronic and age-related diseases. Airlift bioreactors are vital in the production of these products. For instance, in August 2023, the Alliance for Regenerative Medicine reported a 101% increase in cell, gene, and tissue-engineering therapeutic developers since 2022. As biopharmaceutical demand grows, so does the airlift bioreactors market.
The airlift bioreactors market covered in this report is segmented –
1) By Product: Internal Airlift Loop Bioreactor, External Airlift loop Bioreactor
2) By Capacity: 5 Liters, 7 Liters, 10 Liters, 30 Liters
3) By Usage: Single-Use Or Disposal, Reusable
4) By Production Scale: Laboratory Scale, Pilot-Scale, Large Scale
5) By End-User: Biopharmaceutical Companies, Contract Research Organizations (CROs) Or Contract Development And Manufacturing Organizations (CDMOs), Research And Development Companies
Subsegments:
1) By Internal Airlift Loop Bioreactor: Circulating Bioreactor, Non-Circulating Bioreactor
2) By External Airlift Loop Bioreactor: Single-Stage External Airlift Bioreactor, Multi-Stage External Airlift Bioreactor
Companies in the airlift bioreactor market are advancing airlift technology in single-use bioreactors to enhance scalability and operational flexibility. This technology uses gas to circulate and mix the culture broth without mechanical agitation. For example, in March 2022, Cellexus, a UK biotechnology company, introduced airlift single-use bioreactor systems, using bubble-driven circulation to ensure optimal aeration and rapid cell growth with minimal shear forces, offering efficient bioprocessing without impellers.
Major companies operating in the airlift bioreactors market are:
• Lonza Group AG
• Sartorius AG
• Cytiva
• Zeta Global Corp.
• Shanghai Ritai Medicine Equipment Project Co. Ltd.
• Applikon Biotechnology
• Kuhner Shaker Inc
• Tecnal
• bionet
• Bailun Biotechnology Co.Ltd
• ProAnalytics LLC
• IVEN Pharmatech
• Solida Biotech
• LABOAO
• Cellexus
• Electrolab Biotech Ltd
• Shree Biocare Solutions Pvt Ltd
• BioReactor Sciences
• Lab1st Scientific
• Atlas Scientific
• Cedarstone Industry
• Belach Bioteknik AB
• Biojenik Engineering
• Vögtlin Instruments GmbH
• OmniBRx Biotechnologies Pvt Ltd
North America was the largest region in the airlift bioreactor market in 2023. The regions covered in the airlift bioreactors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.